快速部署瓣膜与常规生物瓣膜置换治疗主动脉瓣狭窄的比较
该研究基于德国主动脉瓣注册登记,纳入2011至2015年22,062例孤立性外科主动脉瓣置换患者,比较快速部署瓣膜(RDV)与常规生物瓣膜(CBV)的院内结局。经1:1倾向评分匹配后,RDV组起搏器植入率和致残性卒中率显著高于CBV组,而院内死亡率无显著差异。三种RDV在起搏器植入率和跨瓣压差方面存在差异。
要点
- RDV组起搏器植入率(8.8% vs 3.7%)和致残性卒中率(2.2% vs 0.9%)显著高于CBV组。
- RDV组手术时间、体外循环时间和主动脉阻断时间显著短于CBV组。
- 院内死亡率两组相似(2.2% vs 1.7%),差异无统计学意义。
核心结论
- 在大样本全 comers 数据库中,RDV 的起搏器植入和致残性卒中发生率高于 CBV,而院内死亡率无获益。
- 三种 RDV 在起搏器植入率和术后跨瓣压差方面表现出不同的并发症特征。
研究设计与样本
- 基于德国主动脉瓣注册登记(GARY;NCT01165827)的回顾性队列研究,纳入2011至2015年22,062例孤立性外科主动脉瓣置换患者。
- 采用1:1倾向评分匹配比较CBV与RDV,并比较三种RDV。
主要发现
- RDV组手术时间160 min(25-75百分位:135-195 min)vs CBV组150 min(127-179 min),p<0.001。
- RDV组体外循环时间83 min(68-104 min)vs CBV组70 min(56-87 min),p<0.001。
- RDV组主动脉阻断时间60 min(48-75 min)vs CBV组44 min(35-57 min),p<0.001。
- RDV组起搏器植入率8.8% vs CBV组3.7%,p<0.001;致残性卒中率2.2% vs 0.9%,p<0.001;院内死亡率2.2% vs 1.7%,p=0.22。
- 倾向评分匹配后上述结果持续存在;三种RDV比较显示起搏器率差异无统计学意义,术后跨瓣压差差异有统计学意义。
临床怎么用
- 对于主动脉瓣狭窄患者选择外科生物瓣置换时,需权衡RDV缩短手术时间与增加起搏器植入及致残性卒中风险之间的利弊。
- 不同RDV的并发症特征存在差异,选择具体瓣膜时应考虑起搏器风险和血流动力学表现。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical aortic valve replacement using conventional biological valves (CBVs) is the standard of care for treatment of old patients with aortic valve disease. Recently, rapid deployment valves (RDVs) have been introduced. OBJECTIVES: The purpose of this study was to report the nationwide German experience concerning RDVs for treatment of aortic valve stenosis and provide a head-to-head comparison with CBVs. METHODS: A total of 22,062 patients who underwent isolated surgical aortic valve replacement using CBV or RDV between 2011 and 2015 were enrolled into the German Aortic Valve Registry. Baseline, procedural, and in-hospital outcome parameters were analyzed for CBVs and RDVs using 1:1 propensity score matching. Furthermore, 3 RDVs were compared with each other. RESULTS: A total of 20,937 patients received a CBV, whereas 1,125 patients were treated with an RDV. Patients treated with an RDV presented with significantly reduced procedure (160 min [25th to 75th percentile: 135 to 195 min] vs. 150 min [25th to 75th percentile: 127 to 179 min]; p < 0.001), cardiopulmonary bypass (83 min [25th to 75th percentile: 68 to 104 min] vs. 70 min [25th to 75th percentile: 56 to 87 min]; p < 0.001), and aortic cross clamp times (60 min [25th to 75th percentile: 48 to 75 min] vs. 44 min [25th to 75th percentile: 35 to 57 min]; p < 0.001), but showed significantly elevated rates of pacemaker implantation (3.7% vs. 8.8%; p < 0.001) and disabling stroke (0.9% vs. 2.2%; p < 0.001), whereas in-hospital mortality was similar (1.7% vs. 2.2%; p = 0.22). These findings persisted after 1:1 propensity score matching. Comparison of the 3 RDVs revealed statistically nonsignificant different pacemaker rates and significantly different post-operative transvalvular gradients. CONCLUSIONS: In this large, all-comers database, the incidence of pacemaker implantation and disabling stroke was higher with RDVs, whereas no beneficial effect on in-hospital mortality was seen. The 3 RDVs presented different complication profiles with regard to pacemaker implantation and transvalvular gradients. (German Aortic Valve Registry [GARY]; NCT01165827).
引用
- Ensminger S, Fujita B, Bauer T, et al. Rapid Deployment Versus Conventional Bioprosthetic Valve Replacement for Aortic Stenosis. J Am Coll Cardiol. 2018. PMID: 29598861. doi:10.1016/j.jacc.2018.01.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。